{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:55:38Z","timestamp":1791338138421,"version":"4.3.1"},"reference-count":210,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Medication-related osteonecrosis of the jaw (MRONJ) is a debilitating adverse effect of bisphosphates, antiresorptive therapy or antiangiogenic agents that can potentially increase oxidative stress, leading to progressive osteonecrosis of the jaws. Despite the large number of published systematic reviews, there is a lack of potential MRONJ treatment protocols utilising photobiomodulation (PBM) as a single or adjunct therapy for preventive or therapeutic oncology or non-oncology cohort. Hence, this systematic review aimed to evaluate PBM laser efficacy and its dosimetry as a monotherapy or combined with the standard treatments for preventive or therapeutic approach in MRONJ management. The objectives of the review were as follows: (1) to establish PBM dosimetry and treatment protocols for preventive, therapeutic or combined approaches in MRONJ management; (2) to highlight and bridge the literature gaps in MRONJ diagnostics and management; and (3) to suggest rationalised consensus recommendations for future randomised controlled trials (RCTs) through the available evidence-based literature. This review was conducted according to the PRISMA guidelines, and the protocol was registered at PROSPERO under the ID CRD42021238175. A multi-database search was performed to identify articles of clinical studies published from their earliest records until 15 December 2023. The data were extracted from the relevant papers and analysed according to the outcomes selected in this review. In total, 12 out of 126 studies met the eligibility criteria. The striking inconsistent conclusions made by the various authors of the included studies were due to the heterogeneity in the methodology, diagnostic criteria and assessment tools, as well as in the reported outcomes, made it impossible to conduct a meta-analysis. PBM as a single or adjunct treatment modality is effective for MRONJ preventive or therapeutic management, but it was inconclusive to establish a standardised and replicable protocol due to the high risk of bias in a majority of the studies, but it was possible to extrapolate the PBM dosimetry of two studies that were close to the WALT recommended parameters. In conclusion, the authors established suggested rationalised consensus recommendations for future well-designed robust RCTs, utilising PBM as a monotherapy or an adjunct in preventive or therapeutic approach of MRONJ in an oncology and non-oncology cohort. This would pave the path for standardised PBM dosimetry and treatment protocols in MRONJ management.<\/jats:p>","DOI":"10.3390\/ph17081011","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T08:14:46Z","timestamp":1722500086000},"page":"1011","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A Systematic Review of Laser Photobiomodulation Dosimetry and Treatment Protocols in the Management of Medications-Related Osteonecrosis of the Jaws: A Rationalised Consensus for Future Randomised Controlled Clinical Trials"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2882-2156","authenticated-orcid":false,"given":"Reem","family":"Hanna","sequence":"first","affiliation":[{"name":"Department of Restorative Dental Sciences, UCL-Eastman Dental Institute, Medical Faculty, University College London, London WC1E 6DE, UK"},{"name":"Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana Cristina","family":"Miron","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6601-8551","authenticated-orcid":false,"given":"Snehal","family":"Dalvi","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, 16132 Genoa, Italy"},{"name":"Department of Periodontology, Swargiya Dadasaheb Kalmegh Smruti Dental College and Hospital, Nagpur 440001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Arany","sequence":"additional","affiliation":[{"name":"Department of Oral Biology ad Biomedical Engineering, University of Buffalo, Buffalo, NY 14215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1290-7497","authenticated-orcid":false,"given":"Ren\u00e9 Jean","family":"Bensadoun","sequence":"additional","affiliation":[{"name":"Centre de Haute Energie (CHE), 10, Bd Pasteur, 06000 Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1302-3079","authenticated-orcid":false,"given":"Stefano","family":"Benedicenti","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jocd.2016.09.005","article-title":"Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the international recommendations for management from the international task force on ONJ","volume":"20","author":"Khan","year":"2017","journal-title":"J. Clin. Densitom."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.oooo.2018.11.012","article-title":"Medication-related osteonecrosis of the jaw unrelated to bisphosphonates and denosumab\u2014A review","volume":"127","author":"King","year":"2019","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1620\/tjem.247.75","article-title":"Antiresorptive agent-related osteonecrosis of the jaw (ARONJ): A twist of fate in the bone","volume":"247","author":"Shibahara","year":"2019","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.4317\/medoral.23191","article-title":"Review and update on drugs related to the development of osteonecrosis of the jaw","volume":"25","author":"Eguia","year":"2020","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.oooo.2013.02.001","article-title":"Osteonecrosis of the mandible associated with bevacizumab therapy","volume":"115","author":"Dias","year":"2013","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"8768162","DOI":"10.1155\/2016\/8768162","article-title":"Medications-Related Osteonecrosis of the Jaw: New Insights into Molecular Mechanisms and Cellular Therapeutic Approaches","volume":"2016","author":"Lombard","year":"2016","journal-title":"Stem Cells Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijsu.2019.03.004","article-title":"Teriparatide versus bisphosphonates for treatment of postmenopausal osteoporosis: A meta-analysis","volume":"66","author":"Yuan","year":"2019","journal-title":"Int. J. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Bartl, R., Frisch, B., von Tresckow, E., and Bartl, C. (2007). Bisphosphonates in Medical Practice Actions, Side Effects, Indication, Strategies, Springer.","DOI":"10.1007\/978-3-540-69870-8"},{"key":"ref_9","first-page":"475","article-title":"Adverse effects of bisphosphonates: Current issues","volume":"5","author":"Diel","year":"2007","journal-title":"J. Support. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ans.12018","article-title":"Burden of bisphosphonate-associated femoral fractures","volume":"83","author":"Shkolnikova","year":"2013","journal-title":"ANZ J. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.rdc.2012.09.001","article-title":"Safety of bisphosphonates","volume":"38","author":"Orozco","year":"2012","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00044011-200525020-00003","article-title":"Pharmacokinetic considerations in determining the terminal elimination half-lives of bisphosphonates","volume":"25","author":"Lasseter","year":"2005","journal-title":"Clin. Drug Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00784-009-0266-4","article-title":"Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells","volume":"14","author":"Walter","year":"2010","journal-title":"Clin. Oral Investig."},{"key":"ref_14","first-page":"455","article-title":"Clinical role of bisphosphonate therapy","volume":"4","author":"Hampson","year":"2012","journal-title":"Int. J. Women\u2019s Health"},{"key":"ref_15","first-page":"511","article-title":"Indications des bisphosphonates dans les affections osseuses autres que l\u2019ost\u00e9oporose [Bisphosphonates: Indications in bone diseases other than osteoporosis]","volume":"89","author":"Abdelmoula","year":"2011","journal-title":"Tunis. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ctrv.2018.06.007","article-title":"Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases","volume":"69","author":"Otto","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_17","first-page":"49","article-title":"Bisphosphonate-associated osteonecrosis of the jaw","volume":"70","author":"Ferreira","year":"2021","journal-title":"Minerva Dent. Oral Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1749-6632.2010.05876.x","article-title":"The impact of bisphosphonates on oral health: Lessons from the past and opportunities for the future","volume":"1218","author":"Zavras","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1200\/JCO.2002.06.037","article-title":"American Society of Clinical Oncology clinical practice guidelines: The role of bisphosphonates in multiple myeloma","volume":"20","author":"Berenson","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"115501","DOI":"10.1016\/j.bone.2020.115501","article-title":"On the pharmacological evaluation of bisphosphonates in humans","volume":"139","author":"Cremers","year":"2020","journal-title":"Bone"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10147-013-0561-6","article-title":"Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: A meta-analysis of seven randomized controlled trials","volume":"19","author":"Qi","year":"2014","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/COC.0b013e3182155fcb","article-title":"A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates","volume":"35","author":"Tu","year":"2012","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/annonc\/mdn630","article-title":"Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw [ONJ] and predictors of outcome","volume":"20","author":"Claeys","year":"2009","journal-title":"Ann. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer [excluding breast and prostate cancer] or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw-2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1159\/000343950","article-title":"Incidence and risk factors of bisphosphonate related osteonecrosis of the jaw in multiple myeloma patients having undergone autologous stem cell transplantation","volume":"35","author":"Then","year":"2012","journal-title":"Onkologie"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","article-title":"Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure","volume":"68","author":"Lo","year":"2010","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/annonc\/mdm370","article-title":"A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients","volume":"18","author":"Jadu","year":"2007","journal-title":"Ann. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1007\/s10238-023-01100-6","article-title":"Does medication-related osteonecrosis of the jaw affect survival of patients with Multiple Myeloma? Exploring a large single center database using artificial intelligence","volume":"23","author":"Bittrich","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","article-title":"Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients related with intravenous bisphosphonates","volume":"23","author":"Hoff","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ygyno.2008.11.029","article-title":"Bisphosphonate-induced osteonecrosis of the jaw [ONJ]: Incidence and risk factors in patients with breast cancer and gynecological malignancies","volume":"112","author":"Fehm","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_34","first-page":"3917","article-title":"Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies","volume":"33","author":"Assaf","year":"2013","journal-title":"Anticancer. Res."},{"key":"ref_35","first-page":"c85","article-title":"Physiology and pharmacology of nonbisphosphonate drugs implicated in osteonecrosis of the jaw","volume":"78","author":"Troeltzsch","year":"2012","journal-title":"J. Can. Dent. Assoc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/107327481001700102","article-title":"Current progress in targeted therapy for colorectal cancer","volume":"17","author":"Ortega","year":"2010","journal-title":"Cancer Control"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/1756287216663979","article-title":"Sunitinib in the treatment of metastatic renal cell carcinoma","volume":"8","author":"Schmid","year":"2016","journal-title":"Ther. Adv. Urol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1200\/JCO.2007.15.5424","article-title":"Osteonecrosis of the jaw related to bevacizumab","volume":"26","author":"Estilo","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1517\/14740338.7.4.491","article-title":"Insight into bisphosphonate-associated osteomyelitis of the jaw: Pathophysiology, mechanisms and clinical management","volume":"7","author":"Wimalawansa","year":"2008","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone [osteonecrosis\/osteoporosis] of the jaws: Risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"20580","DOI":"10.1038\/srep20580","article-title":"The effect of bisphosphonates on the endothelial differentiation of mesenchymal stem cells","volume":"6","author":"Sharma","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1601-0825.2010.01720.x","article-title":"Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro","volume":"17","author":"Walter","year":"2011","journal-title":"Oral Dis."},{"key":"ref_43","first-page":"1440","article-title":"Osteonecrosis of the jaws caused by bisphosphonate treatment and oxidative stress in mice","volume":"17","author":"Tamaoka","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00428-007-0516-2","article-title":"Actinomycosis of the jaws-histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis","volume":"451","author":"Hansen","year":"2007","journal-title":"Virchows Arch."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1749-6632.2010.05835.x","article-title":"Potential pathophysiological mechanisms in osteonecrosis of the jaw","volume":"1218","author":"Landesberg","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00774-010-0162-7","article-title":"Bisphosphonate-related osteonecrosis of jaw: Position paper form the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society of Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons","volume":"28","author":"Yoneda","year":"2010","journal-title":"J. Bone Miner. Metab."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jop.12151","article-title":"Oxidative stress in bisphosphonate-related osteonecrosis of the jaws","volume":"43","author":"Bagan","year":"2014","journal-title":"J. Oral Pathol. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00520-019-04793-2","article-title":"The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and\/or bevacizumab","volume":"28","author":"Papadopoulou","year":"2020","journal-title":"Support. Care Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/jbmr.379","article-title":"Periodontal disease and bisphosphonates induced osteonecrosis of the jaws in the rat","volume":"26","author":"Aghaloo","year":"2011","journal-title":"J. Bone Min. Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Otto, S., Aljohani, S., Fliefel, R., Ecke, S., Ristow, O., Burian, E., Troeltzsch, M., Pautke, C., and Ehrenfeld, M. (2021). Infection as an important factor in medication-related osteonecrosis of the jaw (MRONJ). Medicina, 57.","DOI":"10.3390\/medicina57050463"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","article-title":"Low-energy femoral shaft fractures associated with alendronate use","volume":"22","author":"Neviaser","year":"2008","journal-title":"J. Orthop. Trauma"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.joms.2011.08.033","article-title":"Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: Clinical course and outcomes","volume":"70","author":"Lo","year":"2012","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ejim.2013.05.011","article-title":"Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: A retrospective multihospital-based study of 87 Italian cases","volume":"24","author":"Fusco","year":"2013","journal-title":"Eur. J. Intern. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00774-011-0299-z","article-title":"An epidemiological study of alendronate-related osteonecrosis of the jaws. A case series from the south-east of Scotland with attention given to case definition and prevalence","volume":"30","author":"Malden","year":"2012","journal-title":"J. Bone Miner. Metab."},{"key":"ref_56","first-page":"751","article-title":"Oral bisphosphonate- related osteonecrosis of the jaws: Clinical charasteristics of a series of 20 cases in Spain","volume":"17","author":"FernandezFeijoo","year":"2012","journal-title":"Med. Oral Patol. Oral Cir. Bucal."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000342120","article-title":"Association between CYP2C8 [rs1934951] polymorphism and bisphosphonate-related osteonecrosis of the jaws in patients on bisphosphonate therapy: A meta-analysis","volume":"129","author":"Zhong","year":"2013","journal-title":"Acta Haematol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"On, S.W., Cho, S.W., Byun, S.H., and Yang, B.E. (2021). Various Therapeutic Methods for the Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) and Their Limitations: A Narrative Review on New Molecular and Cellular Therapeutic Approaches. Antioxidants, 10.","DOI":"10.3390\/antiox10050680"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Hanna, R., Bensadoun, R.J., Beken, S.V., Burton, P., Carroll, J., and Benedicenti, S. (2022). Outpatient Oral Neuropathic Pain Management with Photobiomodulation Therapy: A Prospective Analgesic Pharmacotherapy-ParalleledFeasibility Trial. Antioxidants, 11.","DOI":"10.3390\/antiox11030533"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Hanna, R., Dalvi, S., Bensadoun, R.J., Raber-Durlacher, J.E., and Benedicenti, S. (2021). Role of Photobiomodulation Therapy in Neurological Primary Burning Mouth Syndrome. A Systematic Review and Meta-Analysis of Human Randomised Controlled Clinical Trials. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13111838"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Hanna, R., Dalvi, S., Bensadoun, R.J., and Benedicenti, S. (2021). Role of Photobiomodulation Therapy in Modulating Oxidative Stress in Temporomandibular Disorders. A Systematic Review and Meta-Analysis of Human Randomised Controlled Trials. Antioxidants, 10.","DOI":"10.3390\/antiox10071028"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Hanna, R., Dalvi, S., Tomov, G., Hopper, C., Rebaudi, F., Rebaudi, A.L., and Bensadoun, J.R. (2023). Emerging potential of phototherapy in management of symptomatic oral lichen planus: A systematic review of randomised controlled clinical trials. J. Biophotonics, 16.","DOI":"10.1002\/jbio.202300046"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Hanna, R., Dalvi, S., Benedicenti, S., Amaroli, A., S\u0103l\u0103gean, T., Pop, I.D., Todea, D., and Bordea, I.R. (2020). Photobiomodulation Therapy in Oral Mucositis and Potentially Malignant Oral Lesions: A Therapy Towards the Future. Cancers, 12.","DOI":"10.3390\/cancers12071949"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Hanna, R., Agas, D., Benedicenti, S., Ferrando, S., Laus, F., Cuteri, V., Lacava, G., Sabbieti, M.G., and Amaroli, A. (2019). A Comparative Study Between the Effectiveness of 980 nm Photobiomodulation Delivered by Hand-Piece with Gaussian vs. Flat-Top Profiles on Osteoblasts Maturation. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00092"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Hanna, R., Dalvi, S., Amaroli, A., De Angelis, N., and Benedicenti, S. (2021). Effects of photobiomodulation on bone defects grafted with bone substitutes: A systematic review of in vivo animal studies. J. Biophotonics, 14.","DOI":"10.1002\/jbio.202000267"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00520-024-08388-4","article-title":"Medication-related osteonecrosis of the jaw: Evolving research for multimodality medical management","volume":"32","author":"Abdolrahmani","year":"2024","journal-title":"Support. Care Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1801676","DOI":"10.1155\/2016\/1801676","article-title":"Medication-Related Osteonecrosis of the Jaws: Considerations on a New Antiresorptive Therapy (Denosumab) and Treatment Outcome after a 13-Year Experience","volume":"2016","author":"Favia","year":"2016","journal-title":"Int. J. Dent."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/cre2.303","article-title":"Conservative non-surgical management in medication related osteonecrosis of the jaw: A retrospective study","volume":"6","author":"Albanese","year":"2020","journal-title":"Clin. Exp. Dent Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"101072","DOI":"10.1016\/j.bonr.2021.101072","article-title":"The Progress of Medication-Related Osteonecrosis of the Jaw with Conservative Initial Treatment: A 12-Year Retrospective Study of 129 Patients","volume":"14","author":"Kaibuchi","year":"2021","journal-title":"Bone Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/osi2.1098","article-title":"Clinicostatistical Analyses of Medication-Related Osteonecrosis of the Jaws (MRONJ): Evaluation of the Treatment Method and Prognosis","volume":"18","author":"Osaka","year":"2021","journal-title":"Oral Sci. Int."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijom.2010.11.013","article-title":"Piezosurgery in oral and maxillofacial surgery","volume":"40","author":"Hanzelka","year":"2011","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1556\/650.2023.32861","article-title":"The recombinant human parathyroid hormone, teriparatide as an alternative remedy for the medication-related osteonecrosis of the jaw","volume":"164","author":"Gera","year":"2023","journal-title":"Orv. Hetil."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jcms.2021.02.023","article-title":"Effect and timing of parathyroid hormone analog administration for preventing medication-related osteonecrosis of the jaws in a murine model","volume":"49","author":"Jung","year":"2021","journal-title":"J. Craniomaxillofacial Surg."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e17196","DOI":"10.5812\/traumamon.17196","article-title":"Platelet-Rich Plasma in Treatment of Zoledronic Acid-Induced Bisphosphonate-Related Osteonecrosis of the Jaws","volume":"19","author":"Sarkarat","year":"2014","journal-title":"Trauma. Mon."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/ID.0b013e31822f7a70","article-title":"Bone Regeneration in the Maxillary Sinus Using an Autologous Fibrin-Rich Block with Concentrated Growth Factors Alone","volume":"20","author":"Sohn","year":"2011","journal-title":"Implant. Dent."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Borsani, E., Bonazza, V., Buffoli, B., Nocini, P.F., Albanese, M., Zotti, F., Inchingolo, F., Rezzani, R., and Rodella, L.F. (2018). Beneficial Effects of Concentrated Growth Factors and Resveratrol on Human Osteoblasts In Vitro Treated with Bisphosphonates. Biomed Res. Int., 2018.","DOI":"10.1155\/2018\/4597321"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2174\/138920112800624382","article-title":"Do the Fibrin Architecture and Leukocyte Content Influence the Growth Factor Release of Platelet Concentrates? An Evidence-Based Answer Comparing a Pure Platelet-Rich Plasma (P-PRP) Gel and a Leukocyte- and Platelet-Rich Fibrin (L-PRF)","volume":"13","author":"Bielecki","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Mijiritsky, E., Assaf, H.D., Kolerman, R., Mangani, L., Ivanova, V., and Zlatev, S. (2022). Autologous Platelet Concentrates (APCs) for Hard Tissue Regeneration in Oral Implantology, Sinus Floor Elevation, Peri-Implantitis, Socket Preservation, and Medication-Related Osteonecrosis of the Jaw (MRONJ): A Literature Review. Biology, 11.","DOI":"10.3390\/biology11091254"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/1389201017666161213152537","article-title":"Molecular, Cellular and Pharmaceutical Aspects of Biomaterials in Dentistry and Oral and Maxillofacial Surgery. An Internationalization of Higher Education and Research Perspective","volume":"18","author":"Wisniewska","year":"2017","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2174\/138920112800624391","article-title":"Current Knowledge and Perspectives for the Use of Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) in Oral and Maxillofacial Surgery Part 1: Periodontal and Dentoalveolar Surgery","volume":"13","author":"Vervelle","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/cbin.10908","article-title":"In Vitro Treatment with Concentrated Growth Factors (CGF) and Sodium Orthosilicate Positively Affects Cell Renewal in Three Different Human Cell Lines","volume":"42","author":"Bonazza","year":"2018","journal-title":"Cell Biol. Int."},{"key":"ref_83","first-page":"304","article-title":"In Vitro Effects of Concentrated Growth Factors (CGF) on Human SH-SY5Y Neuronal Cells","volume":"24","author":"Borsani","year":"2020","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"ref_84","first-page":"23","article-title":"Autologous Platelet Concentrates in Treatment of Medication Related Osteonecrosis of the Jaw","volume":"22","author":"Rusilas","year":"2020","journal-title":"Stomatologija"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jcms.2017.05.028","article-title":"What Is the Effect of Anti-Resorptive Drugs (ARDs) on the Development of Medication-Related Osteonecrosis of the Jaw (MRONJ) in Osteoporosis Patients: A Systematic Review","volume":"45","author":"Aljohani","year":"2017","journal-title":"J. Craniomaxillofacal Surg."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.2174\/138920112800624472","article-title":"Current Knowledge and Perspectives for the Use of Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) in Oral and Maxillofacial Surgery Part 2: Bone Graft, Implant and Reconstructive Surgery","volume":"13","author":"Simonpieri","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.oooo.2018.06.007","article-title":"Can Platelet-Rich Fibrin Improve Healing after Surgical Treatment of Medication-Related Osteonecrosis of the Jaw? A Pilot Study","volume":"126","author":"Giudice","year":"2018","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00784-016-2004-z","article-title":"Platelet-Rich Fibrin May Reduce the Risk of Delayed Recovery in Tooth-Extracted Patients Undergoing Oral Bisphosphonate Therapy: A Trial Study","volume":"21","author":"Asaka","year":"2017","journal-title":"Clin. Oral Investig."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1200\/JCO.19.01186","article-title":"Medication-Related Osteonecrosis of the Jaw: MASCC\/ISOO\/ASCO Clinical Practice Guideline","volume":"37","author":"Yarom","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Hepburn, J., Williams-Lockhart, S., Bensadoun, R.J., and Hanna, R. (2022). A Novel Approach of Combining Methylene Blue Photodynamic Inactivation, Photobiomodulation and Oral Ingested Methylene Blue in COVID-19 Management: A Pilot Clinical Study with 12-Month Follow-Up. Antioxidants, 11.","DOI":"10.3390\/antiox11112211"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3934\/biophy.2017.3.337","article-title":"Mechanisms and applications of the anti-inflammatory effects of photobiomodulation","volume":"4","author":"Hamblin","year":"2017","journal-title":"AIMS Biophys."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2217\/rme.15.82","article-title":"Photobiomodulation in promoting wound healing: A review","volume":"11","author":"Kuffler","year":"2016","journal-title":"Regen. Med."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Dompe, C., Moncrieff, L., Matys, J., Grzech-Lesniak, K., Kocherova, I., Bryja, A., Bruska, M., Dominiak, M., Mozdziak, P., and Skiba, T.H.I. (2020). Photobiomodulation-underlying mechanism and clinical applications. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061724"},{"key":"ref_94","first-page":"7000417","article-title":"Proposed Mechanism of Photobiomodulation or Low-Level Light","volume":"22","author":"Hamblin","year":"2016","journal-title":"Ther. IEEE J. Sel. Top. Quantum Electron."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: The kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref_97","unstructured":"Sterne, J.A.C., Higgins, J.P.T., Elbers, R.G., Reeves, B.C., and the Development Group for ROBINS-I (2024, March 01). Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I): Detailed Guidance, Updated 12 October 2016. Available online: http:\/\/www.riskofbias.info."},{"key":"ref_98","unstructured":"The Cochrane Collaboration (2020). Review Manager (RevMan) [Computer Program]. Version 5.4.1, The Cochrane Collaboration."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/0003-4819-127-9-199711010-00008","article-title":"Quantitative synthesis in systematic reviews","volume":"127","author":"Lau","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"J. Clin. Epidemiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/biom.12817","article-title":"Quantifying publication bias in meta-analysis","volume":"74","author":"Lin","year":"2018","journal-title":"Biometrics"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/pho.2009.2501","article-title":"Effect of low-level laser irradiation on bisphosphonate-induced osteonecrosis of the jaws: Preliminary results of a prospective study","volume":"28","author":"Scoletta","year":"2010","journal-title":"Photomed. Laser Surg."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1089\/pho.2014.3742","article-title":"Low-level laser therapy supported surgical treatment of bisphosphonate related osteonecrosis of jaws: A retrospective analysis of 11 cases","volume":"32","author":"Altay","year":"2014","journal-title":"Photomed. Laser Surg."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s10103-011-0974-2","article-title":"Bisphosphonate-related osteonecrosis: Laser-assisted surgical treatment or conventional surgery?","volume":"26","author":"Atalay","year":"2011","journal-title":"Lasers Med. Sci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/odi.12764","article-title":"Medication-related osteonecrosis of the jaw: Surgical or nonsurgical treatment?","volume":"24","author":"Favia","year":"2018","journal-title":"Oral Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"92","DOI":"10.15171\/jlms.2018.19","article-title":"Combined Approach to Treat Medication-Related Osteonecrosis of the Jaws","volume":"9","author":"Merigo","year":"2018","journal-title":"J. Lasers Med. Sci."},{"key":"ref_108","first-page":"e771","article-title":"Prevention of medication related osteonecrosis of the jaw after dentoalveolar surgery: An institution\u2019s experience","volume":"12","author":"Tatar","year":"2020","journal-title":"J. Clin. Exp. Dent."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bjorl.2021.04.004","article-title":"Combined approach to treatment of advanced stages of medication-related osteonecrosis of the jaw patients","volume":"88","author":"Akan","year":"2022","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/SCS.0000000000001665","article-title":"Tooth extractions in high-risk patients under bisphosphonate therapy and previously affected with osteonecrosis of the jaws: Surgical protocol supported by low-level laser therapy","volume":"26","author":"Vescovi","year":"2015","journal-title":"J. Craniofacial Surg."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/pho.2010.2955","article-title":"Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): A retrospective analysis of 101 treated sites with long-term follow-up","volume":"30","author":"Vescovi","year":"2012","journal-title":"Photomed. Laser Surg."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10103-009-0687-y","article-title":"Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT)","volume":"25","author":"Vescovi","year":"2010","journal-title":"Lasers Med. Sci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"585434","DOI":"10.1155\/2012\/585434","article-title":"Surgical Approach and Laser Applications in BRONJ Osteoporotic and Cancer Patients","volume":"2012","author":"Vescovi","year":"2012","journal-title":"J. Osteoporos."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.4317\/medoral.18812","article-title":"Case series of 589 tooth extractions in patients under bisphosphonates therapy. Proposal of a clinical protocol supported by Nd:YAG low-level laser therapy","volume":"18","author":"Vescovi","year":"2013","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Tenore, G., Zimbalatti, A., Rocchetti, F., Graniero, F., Gaglioti, D., Mohsen, A., Caputo, M., Lollobrigida, M., Lamazza, L., and De Biase, A. (2020). Management of Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Leukocyte- and Platelet-Rich Fibrin (L-PRF) and Photobiomodulation: A Retrospective Study. J. Clin. Med., 9.","DOI":"10.3390\/jcm9113505"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijom.2010.11.002","article-title":"Bisphosphonate-related osteonecrosis of the jaws: A case series of 25 patients affected by osteoporosis","volume":"40","author":"Manfredi","year":"2011","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.oraloncology.2011.08.010","article-title":"Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: A preliminary study","volume":"48","author":"Martins","year":"2012","journal-title":"Oral Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bjoms.2007.03.016","article-title":"Nd:YAG laser biostimulation of bisphosphonate-associated necrosis of the jawbone with and without surgical treatment","volume":"45","author":"Vescovi","year":"2007","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/pho.2007.2181","article-title":"Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: Clinical experience in 28 cases","volume":"26","author":"Vescovi","year":"2008","journal-title":"Photomed. Laser Surg."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pdpdt.2019.05.037","article-title":"Adjunctive application of antimicrobial photodynamic therapy in the prevention of medication-related osteonecrosis of the jaw following dentoalveolar surgery: A case series","volume":"27","author":"Poli","year":"2019","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"101651","DOI":"10.1016\/j.pdpdt.2020.101651","article-title":"Antimicrobial photodynamic and photobiomodulation adjuvant therapies for prevention and treatment of medication-related osteonecrosis of the jaws: Case series and long-term follow-up","volume":"29","author":"Tartaroti","year":"2020","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Erovigni, F.M., Cabras, M., Gambino, A., Todaro, D., Carcieri, P., and Dell\u2019Acqua, A. (Qeios, 2021). Photobiomodulation vs. photodynamic therapy as adjuvant treatments in patients with medication-related osteonecrosis of the jaw (mronj): A pilot study, Qeios, pre-print.","DOI":"10.32388\/RF5D4G"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"107690","DOI":"10.1155\/2014\/107690","article-title":"Conservative surgical management of stage I bisphosphonate-related osteonecrosis of the jaw","volume":"2014","author":"Vescovi","year":"2014","journal-title":"Int. J. Dent."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10103-009-0654-7","article-title":"Osteonecrosis of the jaws caused by bisphosphonates: Evaluation of a new therapeutic approach using the Er:YAG laser","volume":"24","author":"Angiero","year":"2009","journal-title":"Lasers Med. Sci."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Nica, D.F., Rivi\u0219, M., Roi, C.I., Todea, C.D., Duma, V.-F., and Sinescu, C. (2021). Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ). Medicina, 57.","DOI":"10.3390\/medicina57020145"},{"key":"ref_126","first-page":"109","article-title":"Bone necrosis of the jaws associated with bisphosphonate treatment: A report of twenty-nine cases","volume":"77","author":"Merigo","year":"2006","journal-title":"Acta Biomed."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0714.2011.01091.x","article-title":"Bisphosphonates-related osteonecrosis of the jaws: A concise review of the literature and a report of a single-centre experience with 151 patients","volume":"41","author":"Vescovi","year":"2012","journal-title":"J. Oral Pathol. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e20170172","DOI":"10.1590\/1678-7757-2017-0172","article-title":"Osteoradionecrosis of the jaws: Case series treated with adjuvant low-level laser therapy and antimicrobial photodynamic therapy","volume":"26","author":"Ribeiro","year":"2018","journal-title":"J. Appl. Oral Sci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Dioguardi, M., Spirito, F., Alovisi, M., Aiuto, R., Garcovich, D., Crincoli, V., Ballini, A., Caloro, G.A., Muzio, L., and Ballini, A. (2023). Location and Gender Differences in Osteonecrosis of the Jaws in Patients Treated with Antiresorptive and Antineoplastic Drugs Undergoing Dentoalveolar Surgical, Systematic Review with Meta-Analysis and Trial Sequential Analysis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12093299"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/jcpe.12455","article-title":"Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: A systematic review and meta-analysis","volume":"42","author":"Gaudin","year":"2015","journal-title":"J. Clin. Periodontol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"196","DOI":"10.36401\/JIPO-21-14","article-title":"Medication-Related Osteonecrosis of the Jaw in Patients Treated Concurrently with Antiresorptive and Antiangiogenic Agents: Systematic Review and Meta-Analysis","volume":"4","author":"Srivastava","year":"2021","journal-title":"J. Immunother. Precis. Oncol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10006-020-00831-0","article-title":"Laser surgery in management of medication-related osteonecrosis of the jaws: A meta-analysis","volume":"24","author":"Momesso","year":"2020","journal-title":"Oral Maxillofac. Surg."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.oooo.2017.09.014","article-title":"Rapid onset of osteonecrosis of the jaw in patients switching from bisphosphonates to denosumab","volume":"125","author":"Yarom","year":"2018","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Ciobanu, G.A., Mogoant\u0103, L., Popescu, S.M., Ionescu, M., Munteanu, C.M., Staicu, I.E., Mercu\u021b, R., Georgescu, C.C., Scrieciu, M., and Vlad, D. (2023). Correlations between Immune Response and Etiopathogenic Factors of Medication-Related Osteonecrosis of the Jaw in Cancer Patients Treated with Zoledronic Acid. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241814345"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/JPER.19-0385","article-title":"Bisphosphonate-induced reactive oxygen species inhibit proliferation and migration of oral fibroblasts: A pathogenesis of bisphosphonate-related osteonecrosis of the jaw","volume":"91","author":"Taniguchi","year":"2020","journal-title":"J. Periodontol."},{"key":"ref_137","first-page":"56","article-title":"Bisphosphonates related osteonecrosis of the jaw in cancer patients\u2014Epidemiological study","volume":"14","author":"Ciobanu","year":"2022","journal-title":"Rom. J. Oral Rehabil."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Ciobanu, G.A., Mogoant\u0103, L., Camen, A., Ionescu, M., Vlad, D., Staicu, I.E., Munteanu, C.M., Gheorghit, M.I., Mercut, R., and Sin, E.C. (2023). Clinical and Histopathological Aspects of MRONJ in Cancer Patients. J. Clin. Med., 12.","DOI":"10.3390\/jcm12103383"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3803\/EnM.2021.1170","article-title":"Review and Update of the Risk Factors and Prevention of Antiresorptive-Related Osteonecrosis of the Jaw","volume":"36","author":"Kim","year":"2021","journal-title":"Endocrinol. Metab."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00520-020-05855-6","article-title":"Differences between bisphosphonate-related and denosumab-related osteonecrosis of the jaws: A systematic review","volume":"29","author":"Querrer","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Di Fede, O., Canepa, F., Panzarella, V., Mauceri, R., Del Gaizo, C., Bedogni, A., Fusco, V., Tozzo, P., Pizzo, G., and Campisi, G. (2021). The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined Protocols. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18168432"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/jop.13083","article-title":"Weak evidence for the management of medication-related osteonecrosis of the jaw: An overview of systematic reviews and meta-analyses","volume":"50","author":"Moraschini","year":"2021","journal-title":"J. Oral Pathol. Med."},{"key":"ref_143","unstructured":"Campisi, G., Bedogni, A., and Fusco, V. (2024, March 15). Raccomandazioni Clinico-Terapeutiche sull\u2019Osteonecrosi delle ossa Mascellari (ONJ) Farmaco-Relata e sua Prevenzione. Version 2.0-July 2020. Available online: https:\/\/www.sipmo.it\/versione-2-0-delle-raccomandazioni-clinico-terapeutiche-sullosteonecrosi-delle-ossa-mascellari-onj-farmaco-relata-e-sua-prevenzione\/."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"116168","DOI":"10.1016\/j.bone.2021.116168","article-title":"Biologic and pathologic aspects of osteocytes in the setting of medication-related osteonecrosis of the jaw (MRONJ)","volume":"153","author":"Aguirre","year":"2021","journal-title":"Bone"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"De Cicco, D., Boschetti, C.E., Santagata, M., Colella, G., Staglian\u00f2, S., Gaggl, A., Bottini, G.B., Vitagliano, R., and D\u2019amato, S. (2023). Medication-Related Osteonecrosis of the Jaws: A Comparison of SICMF\u2013SIPMO and AAOMS Guidelines. Diagnostics, 13.","DOI":"10.3390\/diagnostics13132137"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.oooo.2019.02.014","article-title":"Association between biomarkers and medication-related osteonecrosis of the jaws: A systematic review","volume":"127","author":"Moraschini","year":"2019","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_148","first-page":"e26","article-title":"Biomarkers to predict the onset of biphosphonate-related osteonecrosis of the jaw: A systematic review","volume":"24","year":"2019","journal-title":"Med. Oral Patol. Oral Cir. Bucal."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijom.2016.10.009","article-title":"Efficacy of the C-terminal telopeptide test in predicting the development of bisphosphonate-related osteonecrosis of the jaw: A systematic review","volume":"46","author":"Lemos","year":"2017","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdsr.2018.11.004","article-title":"Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (1), role of imaging in drug-related osteonecrosis of the jaw: An up-to-date review (secondary publication)","volume":"55","author":"Tsuchimochi","year":"2019","journal-title":"Jpn. Dent. Sci. Rev."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Melguizo-Rodr\u00edguez, L., Costela-Ruiz, V.J., Manzano-Moreno, F.J., Ruiz, C., and Illescas-Montes, R. (2020). Salivary Biomarkers and Their Application in the Diagnosis and Monitoring of the Most Common Oral Pathologies. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21145173"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/jop.12021","article-title":"Bisphosphonates-related osteonecrosis of the jaws: A preliminary study of salivary interleukins","volume":"42","author":"Bagan","year":"2012","journal-title":"J. Oral Pathol. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/odi.12150","article-title":"Interleukin-6 concentration changes in plasma and saliva in bisphosphonate-related osteonecrosis of the jaws","volume":"20","author":"Bagan","year":"2013","journal-title":"Oral Dis."},{"key":"ref_154","first-page":"46","article-title":"Salivary proteomics in bisphosphonate-related osteonecrosis of the jaw","volume":"21","author":"Michalowicz","year":"2013","journal-title":"Oral Dis."},{"key":"ref_155","first-page":"738","article-title":"Serum Markers of Bone Turnover and Angiogenesis in Patients with Bisphosphonate-Related Osteonecrosis of the Jaw after Discontinuation of Long-Term Intravenous Bisphosphonate Therapy","volume":"74","author":"Michalowicz","year":"2015","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"279","DOI":"10.11005\/jbm.2021.28.4.279","article-title":"Medication Related Osteonecrosis of the Jaw: 2021 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons","volume":"28","author":"Kim","year":"2021","journal-title":"J. Bone Metab."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/ijcp.12022","article-title":"Denosumab: Mechanism of action and clinical outcomes","volume":"66","author":"Hanley","year":"2012","journal-title":"Int. J. Clin. Pract."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","article-title":"Osteonecrosis of the jaws in patients treated with bisphosphonates-histomorphologic analysis in comparison with infected osteoradionecrosis","volume":"35","author":"Hansen","year":"2006","journal-title":"J. Oral Pathol. Med."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"23247096241258076","DOI":"10.1177\/23247096241258076","article-title":"Novel Histopathological Findings of Micro Bone Fragments and Epithelial Response in the Oral Mucosa in Bisphosphonate-Related Osteonecrosis of the Jaw","volume":"12","author":"Koizumi","year":"2024","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.oooo.2012.08.444","article-title":"Metagenomic investigation of microbes and viruses in patients with jaw osteonecrosis associated with bisphosphonate therapy","volume":"114","author":"Sedghizadeh","year":"2012","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ijos.2014.46","article-title":"Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw","volume":"6","author":"Pushalkar","year":"2014","journal-title":"Int. J. Oral Sci."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"115676","DOI":"10.1016\/j.bone.2020.115676","article-title":"Adjuvant therapies for MRONJ: A systematic review","volume":"141","author":"Govaerts","year":"2020","journal-title":"Bone"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.job.2019.03.005","article-title":"Medication-related osteonecrosis of the jaw: A literature review","volume":"61","author":"Kuroshima","year":"2019","journal-title":"J. Oral Biosci."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e03795","DOI":"10.1016\/j.heliyon.2020.e03795","article-title":"Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic review","volume":"6","author":"Ottesen","year":"2020","journal-title":"Heliyon"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"on behalf of the International Task Force on Osteonecrosis of the Jaw, Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Min. Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tripleo.2010.04.015","article-title":"The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw","volume":"111","author":"Wilde","year":"2011","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_167","first-page":"e141","article-title":"Prophylaxis and antibiotic therapy in management protocols of patients treated with oral and intravenous bisphosphonates","volume":"9","year":"2017","journal-title":"J. Clin. Exp. Dent."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.oooo.2017.11.022","article-title":"Microbial population changes in patients with medication-related osteonecrosis of the jaw treated with systemic antibiotics","volume":"125","author":"Coropciuc","year":"2018","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.archoralbio.2014.05.002","article-title":"Important aspects regarding the role of microorganisms in bisphosphonate-related osteonecrosis of the jaws","volume":"59","author":"Boff","year":"2014","journal-title":"Arch. Oral Biol."},{"key":"ref_170","first-page":"64","article-title":"Etiologic Role of Bacterial Microorganisms in Medication Related Osteonecrosis of the Jaws: A Systematic Review","volume":"9","author":"Shamsoddin","year":"2019","journal-title":"Int. J. Pharm. Phytopharm."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Kiss, C., Connoley, D., Connelly, K., Horne, K., Korman, T., Woolley, I., and Lau, J.S.Y. (2022). Long-Term Outcomes in Patients on Life-Long Antibiotics: A Five-Year Cohort Study. Antibiotics, 11.","DOI":"10.3390\/antibiotics11010062"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"e02462-18","DOI":"10.1128\/AAC.02462-18","article-title":"Predicting antibiotic resistance in gram-negative bacilli from resistance genes","volume":"63","author":"Walker","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1601-0825.2011.01848.x","article-title":"Antibiotic effects on bacterial profile in osteonecrosis of the jaw","volume":"18","author":"Ji","year":"2012","journal-title":"Oral Dis."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00784-020-03595-9","article-title":"Retrospective analysis of bacterial colonization of necrotic bone and antibiotic resistance in 98 patients with medication-related osteonecrosis of the jaw (MRONJ)","volume":"25","author":"Ewald","year":"2021","journal-title":"Clin. Oral Investig."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.joms.2015.09.029","article-title":"Effects of Antiseptic Solutions Commonly Used in Dentistry on Bone Viability, Bone Morphology, and Release of Growth Factors","volume":"74","author":"Sawada","year":"2016","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jcms.2020.01.014","article-title":"Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review","volume":"48","author":"Fortunato","year":"2020","journal-title":"J. Craniomaxillofacial Surg."},{"key":"ref_177","first-page":"62","article-title":"Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention","volume":"51","author":"Gallesio","year":"2015","journal-title":"A systematic review of the literature. Eur. J. Cancer"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Scribante, A., Ghizzoni, M., Pellegrini, M., Pulicari, F., and Spadari, F. (2023). Laser Devices and Autologous Platelet Concentrates in Prevention and Treatment of Medication-Related Osteonecrosis of the Jaws: A Systematic Review. Medicina, 59.","DOI":"10.3390\/medicina59050972"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jcms.2008.12.004","article-title":"Bisphosphonate related osteonecrosis of the jaws treated by surgical resection and immediate osseous microvascular reconstruction","volume":"37","author":"Haarmann","year":"2009","journal-title":"J. Craniomaxillofacial Surg."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jcms.2014.11.014","article-title":"Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ)","volume":"43","author":"Ristow","year":"2015","journal-title":"J. Craniomaxillofacial Surg."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.joms.2017.10.024","article-title":"Can Autofluorescence Guide Surgeons in the Treatment of Medication-Related Osteonecrosis of the Jaw? A Prospective Feasibility Study","volume":"76","author":"Giudice","year":"2018","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10103-007-0475-5","article-title":"Comparative histological analysis of bone healing of standardized bone defects performed with the Er:YAG laser and steel burs","volume":"23","author":"Pagnoncelli","year":"2008","journal-title":"Lasers Med. Sci."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1002\/hed.25944","article-title":"Adjuvant therapies in the management of medication-related osteonecrosis of the jaws: Systematic review","volume":"41","author":"Michellon","year":"2019","journal-title":"Head Neck"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.oraloncology.2012.07.008","article-title":"Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws (BRONJs)","volume":"49","author":"Holzinger","year":"2013","journal-title":"Oral Oncol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/oral2020014","article-title":"ONJ (MRONJ) Update 2021\u2014Osteonecrosis of Jaw Related to Bisphosphonates and Other Drugs\u2014Prevention, Diagnosis, Pharmacovigilance, Treatment: A 2021 Web Event","volume":"2","author":"Fusco","year":"2022","journal-title":"Oral"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/0022034515572021","article-title":"Infection and medication-related osteonecrosis of the jaw","volume":"94","author":"Katsarelis","year":"2015","journal-title":"J. Dent. Res."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.2010.05768.x","article-title":"Bisphosphonate-related osteonecrosis of the jaw: An overview","volume":"1218","author":"Ruggiero","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jcms.2016.05.004","article-title":"Medication-Related Osteonecrosis of the Jaw: Is Autologous Platelet Concentrate Application Effective for Prevention and Treatment? A Systematic Review","volume":"44","author":"Tobias","year":"2016","journal-title":"J. Craniomaxillofacial Surg."},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Porcaro, G., Caccianiga, P., Bader, A.A., and Caccianiga, G. (2022). Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) with Er:YaG Laser and Ozone Therapy: A Case Series. Inventions, 7.","DOI":"10.3390\/inventions7040097"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jfma.2012.04.010","article-title":"Clinical treatment outcomes for 40 patients with bisphosphonates-related osteonecrosis of the jaws","volume":"113","author":"Lee","year":"2014","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Khan, I., Rahman, S.U., Tang, E., Engel, K., Hall, B., Kulkarni, A.B., and Arany, P.R. (2021). Accelerated burn wound healing with photobiomodulation therapy involves activation of endogenous latent TGF-\u03b21. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-92650-w"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"102889","DOI":"10.1016\/j.pdpdt.2022.102889","article-title":"Photodynamic therapy and photobiomodulation therapy in zoledronic acid-induced osteonecrosis in rats","volume":"38","author":"Lima","year":"2022","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1479-5876-9-102","article-title":"Bisphosphonate-associated osteonecrosis of the jaw is linked to suppressed TGF\u03b21-signaling and increased Galectin-3 expression: A histological study on biopsies","volume":"9","author":"Wehrhan","year":"2011","journal-title":"J. Transl. Med."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jbmr.2985","article-title":"IL-36 induces bisphosphonate-related osteonecrosis of the jaw-like lesions in mice by inhibiting TGF-\u03b2-mediated collagen expression","volume":"32","author":"Kim","year":"2017","journal-title":"J. Bone Min. Res."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12967-019-2129-3","article-title":"Identifying genetic variants underlying medication-induced osteonecrosis of the jaw in cancer and osteoporosis: A case control study","volume":"17","author":"Lee","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Robijns, J., Nair, R.G., Lodewijckx, J., Arany, P., Barasch, A., Bjordal, J.M., Bossi, P., Chilles, A., Corby, P.M., and Epstein, J.B. (2022). Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.927685"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1210\/jc.2015-1794","article-title":"Declining incidence of medication-related osteonecrosis of the jaw in patients with cancer","volume":"100","author":"Sim","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.oooo.2018.09.008","article-title":"Medication-related osteonecrosis of the jaw: Definition and best practice for prevention, diagnosis, and treatment","volume":"127","author":"Mendes","year":"2019","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00784-016-1762-y","article-title":"Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab","volume":"21","author":"Matsumoto","year":"2017","journal-title":"Clin. Oral Investig."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s00198-017-4063-7","article-title":"A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: Can primary wound closure and a drug holiday really prevent MRONJ?","volume":"28","author":"Hasegawa","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_201","first-page":"Cd012432","article-title":"Interventions for managing medication-related osteonecrosis of the jaw","volume":"2022","author":"Mayer","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_202","first-page":"1419","article-title":"Management and maintenance of oral health: Personalized primary prevention strategies and protocols in patients at risk of developing medication-related osteonecrosis of the jaw","volume":"7","author":"Mosaico","year":"2024","journal-title":"INNOSC Pharmacol. Sci."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.oraloncology.2014.08.016","article-title":"A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ)","volume":"50","author":"Rupel","year":"2014","journal-title":"Oral Oncol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s10103-016-1929-4","article-title":"Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): A systematic review","volume":"31","author":"Weber","year":"2016","journal-title":"Lasers Med. Sci."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bjoms.2019.12.001","article-title":"Effectiveness of laser-assisted treatments for medication-related osteonecrosis of the jaw: A systematic review","volume":"58","author":"Li","year":"2020","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/photob.2022.0084","article-title":"Efficacy of Adjunctive Photobiomodulation in the Management of Medication-Related Osteonecrosis of the Jaw: A Systematic Review","volume":"40","author":"Razavi","year":"2022","journal-title":"Photobiomodulation Photomed. Laser Surg."},{"key":"ref_207","first-page":"881","article-title":"ASCO clinical practice guidelines: Process, progress, pitfalls, and prospects","volume":"4","author":"Somerfield","year":"2000","journal-title":"Class. Pap. Curr. Comments"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"100339","DOI":"10.1016\/j.conctc.2019.100339","article-title":"A practical approach to sample size calculation for fixed populations","volume":"14","author":"Kaptein","year":"2019","journal-title":"Contemp. Clin. Trials Commun."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/j.oooo.2022.01.768","article-title":"clinical effectiveness of photodynamic antimicrobial therapy in mronj\u2014Systematic review","volume":"134","author":"Oliveira","year":"2022","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Zheng, Y., Dong, X., Chen, S., He, Y., An, J., Liu, M., He, L., and Zhang, Y. (2023). Low-level laser therapy prevents medication-related osteonecrosis of the jaw-like lesions via IL-1RA-mediated primary gingival wound healing. BMC Oral Health, 23.","DOI":"10.1186\/s12903-022-02678-1"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/8\/1011\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:27:39Z","timestamp":1760110059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/8\/1011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":210,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["ph17081011"],"URL":"https:\/\/doi.org\/10.3390\/ph17081011","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]}}}